GT Medical Technologies has appointed Per Langoe as its new CEO.
Langoe brings more than 20 years of commercial, clinical, and mergers and acquisitions experience to the post. Previously he was co-founder, president, and CEO of Palette Life Sciences.
He succeeds Matt Likens, founding CEO of GT Medical Technologies, who retired in January.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
